Complete Remission of del(5q) Myelodysplastic Syndrome after 7 Days of Lenalidomide Therapy Gives an Alert!

Publisher： Karger

E-ISSN： 1662-6575|5|3|586-591

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.5, Iss.3, 2012-10, pp. : 586-591

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Megakaryocytes harbour the del(5q) abnormality despite complete clinical and cytogenetic remission induced by lenalidomide treatment

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 4, 2018-02 ,pp. : 526-533

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Response in a Patient with del(5q) Myelodysplastic Syndrome Who Discontinued Lenalidomide and Obtained a Good Response and Tolerance to Rechallenge

By  

Case Reports in Oncology, Vol. 7, Iss. 1, 2014-04 ,pp. : 277-284

Karger

Access to resources Recommend Favorite

A Case of Plasmablastic Lymphoma Achieving Complete Response and Durable Remission after Lenalidomide-Based Therapy

By  

Oncology Research and Treatment, Vol. 40, Iss. 1-2, 2017-01 ,pp. : 46-48

Karger

Access to resources Recommend Favorite

Complete Remission with a Combination of Lenalidomide, Cyclophosphamide and Prednisolone in a Patient with Incomplete POEMS Syndrome

By  

Acta Haematologica, Vol. 126, Iss. 4, 2011-08 ,pp. : 199-201

Karger

Access to resources Recommend Favorite

Complete Remission of Hypereosinophilic Syndrome after Interferon‐α Therapy: Report of a Case and Literature Review

By  

THE JOURNAL OF DERMATOLOGY, Vol. 27, Iss. 2, 2000-02 ,pp. : 110-115

John Wiley & Sons Inc

Access to resources Recommend Favorite